SPY425.10+2.50 0.59%
DIA341.98+3.20 0.94%
IXIC14,369.71+97.98 0.69%

Stoke Therapeutics Posts Wider Q1 Net Loss

05/10/2021 05:02

08:53 AM EDT, 05/10/2021 (MT Newswires) -- Stoke Therapeutics (STOK) reported a wider Q1 net loss Monday of $0.46 per diluted share, compared with a net loss of $0.34 a year earlier. Analysts polled by Capital IQ expected a loss of $0.45.

The biotechnology company said at the quarter ended March 31 it had cash, cash equivalents and restricted cash of $267.7 million, anticipated to fund its operations into 2024.

Price: 32.75, Change: +0.29, Percent Change: +0.89